Comparison between Hindustan Laboratories IPO and Marri Retail IPO.
Hindustan Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Marri Retail IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Hindustan Laboratories IPO is up to ₹0.00 Cr whereas the issue size of the Marri Retail IPO is up to ₹0.00 Cr. The final issue price of Hindustan Laboratories IPO is and of Marri Retail IPO is .
| Hindustan Laboratories IPO | Marri Retail IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 50,00,000 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹522.00 Cr |
| OFS Issue Size | 91,00,000 shares | 2,70,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,41,00,000 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Hindustan Laboratories IPO opens on , while Marri Retail IPO opens on . The closing date of Hindustan Laboratories IPO and Marri Retail IPO is , and , respectively.
Hindustan Laboratories IPO P/E ratio is , as compared to Marri Retail IPO P/E ratio of .
| Hindustan Laboratories IPO | Marri Retail IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 25.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 33.13% | 14.72% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.69 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 26.11% | 22.58% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Hindustan Laboratories IPO Retail Individual Investors (RII) are offered 0 shares while in Marri Retail IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Hindustan Laboratories IPO and 0 shares in Marri Retail IPO.
| Hindustan Laboratories IPO | Marri Retail IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Hindustan Laboratories IPO subscribed in total, whereas Marri Retail IPO subscribed .
